ARCHIVES

Funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

May 26, 1995

“Honor Roll” Of Top Investigators Who Won’t Be Funded Because Of Cuts

March 8, 1985

HCFA Sees Applications For DRGs And Research

September 27, 1985

Contracts Awarded For $30 Million Heavy Smokers Clinical Trials

October 10, 1986